![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
David Andrews, Vishva Dixit, Gerard Evan, Anthony Letai, Jean Claude Martinou, Pascal Meier, Gerry Melino, Dale Porter, Meike Vogler, Karen Vousden, Domagoj Vucic, Henning Walczak, David Wallach
Thursday 14 June 2012, 09:00-19:00
Apoptosis and Cancer
- đ¤ Speaker: David Andrews, Vishva Dixit, Gerard Evan, Anthony Letai, Jean Claude Martinou, Pascal Meier, Gerry Melino, Dale Porter, Meike Vogler, Karen Vousden, Domagoj Vucic, Henning Walczak, David Wallach
- đ Date & Time: Thursday 14 June 2012, 09:00 - 19:00
- đ Venue: Downing College, Regent Street, Cambridge, UK
Abstract
Meeting website: www.abcam.com/cambridgecancer
A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and inhibitor of apoptosis proteins (IAPs). Discussion sessions will involve members from academia as well as industry.
Series This talk is part of the Abcam meetings series.
Included in Lists
Note: Ex-directory lists are not shown.